View in EDS HTML Full Text PDF Full Text

Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRASG12D-mutated pancreatic cancer.

Saved in:

Bibliographic Details
Title:	Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRAS^G12D-mutated pancreatic cancer.
Authors:	Xiao, Jeffrey¹ (AUTHOR), Kim, Joshua¹ (AUTHOR), Park, Brandon¹ (AUTHOR), Baylink, David J.¹ (AUTHOR), Kwon, Cedric¹ (AUTHOR), Tran, Victoria¹ (AUTHOR), Lee, Scott² (AUTHOR), Codorniz, Kevin² (AUTHOR), Tan, Laren³ (AUTHOR), Moreno, Pamela Lobo³ (AUTHOR), Schill-Depew, Amy³ (AUTHOR), Mirshahidi, Saied^4,5,6 (AUTHOR), De Semir, David⁷ (AUTHOR), Hanna, Diana⁸ (AUTHOR), Naqvi, Kiran⁹ (AUTHOR), Cao, Huynh^5,6 (AUTHOR), Chen, Chien-Shing^5,6 (AUTHOR), Xiu, Joanne⁷ (AUTHOR), Lenz, Heinz-Josef⁸ (AUTHOR), Mirshahidi, Hamid^5,6 (AUTHOR)
Source:	Experimental Hematology & Oncology. 5/26/2025, Vol. 14 Issue 1, p1-6. 6p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!